eng

SITE MAP

Overview

Provider

  • Home
  • Provider
  • Overview

01

About the test

Early Detection of Cancer with a Single Blood Draw
Cancer cell-derived cfDNA is analyzed through
NGS technology and bioinformatics to provide
personalized guidance to the customer.

02

Benefits

Provides comprehensive cancer profiling
using a single blood draw

Early screening and convenient diagnosis for cancer

03

Test Options

  • cancer screening

    Screening test

    detect and analyze cancer
    related mutant genes in
    asymptomatic patients

  • therapy

    Companion
    diagnotics(CDx)

    screening service providing
    the basis for personalized
    medicine prescription

  • cancer monitoring

04

Test details

How is the
oncocatch
performed

  • Specimen

    Blood 10mL

  • TAT

    Depends on
    each test option

  • Test Method

    NGS

#291 Harmony-ro, Yeonsu-gu, Incheon, 22014, South Korea

EDGE | Name of Representative : Min-Seob Lee

Tel : +82-32-713-2100 | Email : info@edgc.com | Business Registration Number : 131-86-48582

EDGC, Inc. | #143, Gaetbeol-ro, Yeonsu-gu, Incheon, 21999, South Korea | Tel : +1-800-605-8422

ⓒ[2023]. Eone Diagnomics Genome Center Co., Ltd. All Rights Reserved.